EP1169440A4 - 48 human secreted proteins - Google Patents
48 human secreted proteinsInfo
- Publication number
- EP1169440A4 EP1169440A4 EP00917960A EP00917960A EP1169440A4 EP 1169440 A4 EP1169440 A4 EP 1169440A4 EP 00917960 A EP00917960 A EP 00917960A EP 00917960 A EP00917960 A EP 00917960A EP 1169440 A4 EP1169440 A4 EP 1169440A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12581299P | 1999-03-23 | 1999-03-23 | |
US125812P | 1999-03-23 | ||
US16993699P | 1999-12-10 | 1999-12-10 | |
US169936P | 1999-12-10 | ||
PCT/US2000/006782 WO2000056881A1 (en) | 1999-03-23 | 2000-03-16 | 48 human secreted proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1169440A1 EP1169440A1 (en) | 2002-01-09 |
EP1169440A4 true EP1169440A4 (en) | 2004-01-14 |
Family
ID=26823977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00917960A Withdrawn EP1169440A4 (en) | 1999-03-23 | 2000-03-16 | 48 human secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1169440A4 (en) |
JP (1) | JP2004506402A (en) |
AU (1) | AU3885400A (en) |
CA (1) | CA2365238A1 (en) |
WO (1) | WO2000056881A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002253104A1 (en) * | 2001-03-07 | 2002-09-19 | Galapagos Genomics B.V. | Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
CA2510315C (en) | 2002-12-20 | 2014-01-28 | Protein Design Labs, Inc. | Antibodies against gpr64 and uses thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045712A2 (en) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 human secreted proteins |
EP1074617A2 (en) * | 1999-07-29 | 2001-02-07 | Helix Research Institute | Primers for synthesising full-length cDNA and their use |
WO2001042511A2 (en) * | 1999-12-10 | 2001-06-14 | Whitehead Institute For Biomedical Research | Ibd-related polymorphisms |
WO2001057182A2 (en) * | 2000-01-31 | 2001-08-09 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
-
2000
- 2000-03-16 JP JP2000606740A patent/JP2004506402A/en not_active Withdrawn
- 2000-03-16 EP EP00917960A patent/EP1169440A4/en not_active Withdrawn
- 2000-03-16 CA CA002365238A patent/CA2365238A1/en not_active Abandoned
- 2000-03-16 WO PCT/US2000/006782 patent/WO2000056881A1/en not_active Application Discontinuation
- 2000-03-16 AU AU38854/00A patent/AU3885400A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045712A2 (en) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 human secreted proteins |
EP1074617A2 (en) * | 1999-07-29 | 2001-02-07 | Helix Research Institute | Primers for synthesising full-length cDNA and their use |
WO2001042511A2 (en) * | 1999-12-10 | 2001-06-14 | Whitehead Institute For Biomedical Research | Ibd-related polymorphisms |
WO2001057182A2 (en) * | 2000-01-31 | 2001-08-09 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
Non-Patent Citations (10)
Title |
---|
DATABASE EBI [online] 14 April 1995 (1995-04-14), XP002237934, Database accession no. T95815 * |
DATABASE EBI [online] 14 April 1995 (1995-04-14), XP002237935, Database accession no. T95814 * |
DATABASE EBI [online] 15 September 1995 (1995-09-15), XP002237933, Database accession no. R99876 * |
DATABASE EBI [online] 15 September 1995 (1995-09-15), XP002237936, Database accession no. R99875 * |
DATABASE EBI [online] 22 July 1998 (1998-07-22), XP002237932, Database accession no. AI057466 * |
DATABASE EBI [online] 6 October 1999 (1999-10-06), XP002237937, Database accession no. AC011004 * |
DATABASE EMBL [online] XP002237994, Database accession no. AAH17266 * |
DATABASE EMBL [online] XP002237995, Database accession no. AAK78465 * |
DATABASE EMBL [online] XP002238059, Database accession no. AX182344 * |
See also references of WO0056881A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000056881A1 (en) | 2000-09-28 |
JP2004506402A (en) | 2004-03-04 |
CA2365238A1 (en) | 2000-09-28 |
AU3885400A (en) | 2000-10-09 |
EP1169440A1 (en) | 2002-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1218408A4 (en) | 32 human secreted proteins | |
EP1212343A4 (en) | 52 human secreted proteins | |
EP1181390A4 (en) | 27 human secreted proteins | |
EP1224285A4 (en) | 27 human secreted proteins | |
EP1212342A4 (en) | 18 human secreted proteins | |
EP1226231A4 (en) | 19 human secreted proteins | |
EP1175438A4 (en) | 62 human secreted proteins | |
EP1192278A4 (en) | 48 human secreted proteins | |
EP1175439A4 (en) | 49 human secreted proteins | |
EP1165827A4 (en) | 45 human secreted proteins | |
EP1192176A4 (en) | 49 human secreted proteins | |
EP1159284A4 (en) | 33 human secreted proteins | |
EP1189917A4 (en) | 48 human secreted proteins | |
EP1185543A4 (en) | 50 human secreted proteins | |
EP1224201A4 (en) | 32 human secreted proteins | |
EP1173477A4 (en) | 49 human secreted proteins | |
EP1206573A4 (en) | 26 human secreted proteins | |
EP1203005A4 (en) | 25 human secreted proteins | |
EP1169332A4 (en) | 49 human secreted proteins | |
EP1171460A4 (en) | 48 human secreted proteins | |
EP1144614A4 (en) | 33 human secreted proteins | |
EP1165602A4 (en) | 49 human secreted proteins | |
EP1165828A4 (en) | 50 human secreted proteins | |
EP1185285A4 (en) | 49 human secreted proteins | |
EP1228082A4 (en) | 29 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011018 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20031201 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20040505 |